Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening.
McLean, L.R., Zhang, Y., Li, H., Li, Z., Lukasczyk, U., Choi, Y.M., Han, Z., Prisco, J., Fordham, J., Tsay, J.T., Reiling, S., Vaz, R.J., Li, Y.(2009) Bioorg Med Chem Lett 19: 6717-6720
- PubMed: 19836948 
- DOI: https://doi.org/10.1016/j.bmcl.2009.09.106
- Primary Citation of Related Structures:  
3JSF, 3JSG, 3JTU - PubMed Abstract: 
Biochemical and X-ray crystallographic studies confirmed that hydroxyquinoline derivatives identified by virtual screening were actually covalent inhibitors of the MIF tautomerase. Adducts were formed by N-alkylation of the Pro-1 at the catalytic site with a loss of an amino group of the inhibitor.
Organizational Affiliation: 
Discovery Research, sanofi-aventis, Bridgewater, NJ 08807, USA. Larry.Mclean@sanofi-aventis.com